Pulmonary ventilation–perfusion (V/Q) scintigraphy is one of the oldest procedures in nuclear medicine. Planar V/Q imaging was the standard of care for evaluating patients with suspected PE until the ...

Lung biopsy is a relatively frequently performed procedure with considerable benefit for patient management but it may, on rare occasions, result in the death of the patient. It is a multidisciplinary ...

Lung cancer screening aims to find lung cancer early. This is when there are more treatment options available and there is the best chance of treating it successfully. In the UK, the National ...

The gold standard for finding lung cancer early is computed tomography (CT) lung cancer screening. However, this is limited to people who have smoked. Currently, there are more non-smokers (never ...

All patients alive at the beginning of March 2012, and with a PE diagnosis confirmed by CT pulmonary angiogram or high probability perfusion scintigraphy, were eligible for study participation.

COPD is a progressive lung disease with mild symptoms in the early stages that gradually worsen. Early diagnosis and treatment can help preserve lung function. People with COPD often have trouble ...

Lung cancer is one of the most common types of cancer in the United States and a leading cause of cancer deaths. However, the timeline of how the disease progresses can vary based on several factors.

Lung cancer is a form of cancer wherein abnormal cells start to grow in the lungs in an uncontrolled way. According to World Cancer Research Fund, there were nearly 2.4 million new cases of lung ...

To diagnose chronic obstructive pulmonary disease (COPD), doctors typically use spirometry to measure your lung function. They usually also perform other tests to monitor the damage to your lungs.

This change is a result of two concurrent advances in the field. The first is the advent of a nonbiopsy method using technetium-labeled bone scintigraphy to diagnose the condition in patients for whom ...

Pulmonary fibrosis (PF) is a terminal change of a lung disease that is marked by damage to alveolar epithelial cells, abnormal proliferative transformation of fibroblasts, excessive deposition of ...